18541787

Source:http://linkedlifedata.com/resource/pubmed/id/18541787

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0010583, umls-concept:C0012634, umls-concept:C0026769, umls-concept:C0030705, umls-concept:C0231170, umls-concept:C0301630, umls-concept:C0441655, umls-concept:C0580822, umls-concept:C1547300, umls-concept:C1548760, umls-concept:C1550594
pubmed:issue	8
pubmed:dateCreated	2008-8-12
pubmed:abstractText	To explore the safety and effectiveness of high-dose cyclophosphamide (HiCy) without bone marrow transplantation in patients with aggressive multiple sclerosis (MS).
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/M01 RR000052-46, http://linkedlifedata.com/resource/pubmed/grant/M01-RR000052
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-10355672, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-10571379, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-10713630, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-10798604, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-11286782, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-11445629, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-11511721, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-11513020, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-1157430, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-11990872, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-12195460, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-12509845, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-12528116, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-1401906, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-15725909, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-15885298, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-16040220, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-1637140, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-1671468, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-16908728, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-17263012, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-17604116, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-1921949, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-2784607, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-2957983, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-3276298, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-3818941, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-6354151, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-8388090, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-8877390, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-9307263, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-9383225, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-9808541, http://linkedlifedata.com/resource/pubmed/commentcorrection/18541787-9867758
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372436
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1538-3687
pubmed:author	pubmed-author:BrodskyRobert ARA, pubmed-author:CalabresiPeter APA, pubmed-author:DrachmanDaniel BDB, pubmed-author:GreenbergBenjamin MBM, pubmed-author:HammondEdwardE, pubmed-author:JonesRichard JRJ, pubmed-author:KaplinAdam IAI, pubmed-author:KerrDouglas ADA, pubmed-author:KrishnanChitraC, pubmed-author:McArthurJustin CJC, pubmed-author:NathAvindraA, pubmed-author:PardoCarlos ACA, pubmed-author:PhamDzung LDL, pubmed-author:QuiggMeganM, pubmed-author:RichertNancy DND, pubmed-author:TreckerCarrilinC, pubmed-author:YousemDavid MDM
pubmed:issnType	Electronic
pubmed:volume	65
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1044-51
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:18541787-Adult, pubmed-meshheading:18541787-Cohort Studies, pubmed-meshheading:18541787-Cyclophosphamide, pubmed-meshheading:18541787-Disability Evaluation, pubmed-meshheading:18541787-Female, pubmed-meshheading:18541787-Follow-Up Studies, pubmed-meshheading:18541787-Humans, pubmed-meshheading:18541787-Male, pubmed-meshheading:18541787-Middle Aged, pubmed-meshheading:18541787-Multiple Sclerosis, Relapsing-Remitting, pubmed-meshheading:18541787-Treatment Outcome
pubmed:year	2008
pubmed:articleTitle	Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis.
pubmed:affiliation	Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287-5371, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural